MCK catalysts
Catalysts and events linked to MCK, newest first.
MCK stock catalysts and risks
Latest published review: 2026-10-21
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| McKesson outperforms with strong Q4 and full-year earnings outlook 2026-10-21 · Up | defensive healthcare multiple support via recent share-price strength | McKesson closed at $1,030.12 and has gained 13.98% over the past month. | Not recorded |
Do these developments change your position?
Review MCK alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-10-21McKesson outperforms with strong Q4 and full-year earnings outlookMCK
- 2026-05-21Revenue Cycle Management Market to Hit $663.3B by 2035MCK UNH-0.57%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.